Morphological changes of megakaryocytes in acute myelogenous leukemia and preleukemic phase
Izumiguchi, Y.; Iwanaga, Y.; Nasu, M.; Sato, T.; Fujita, S.; Kai, S.; Krosaki, M.; Hara, H.
Rinsho Byori. Japanese Journal of Clinical Pathology 27(1): 73-76
1979
ISSN/ISBN: 0047-1860 PMID: 285272 Document Number: 141159
Document emailed within 1 workday
Related Documents
Aurer, I.; Canaani, E.; Gale, R.P. 1991: Hypothesis: additional cytogenetic abnormalities and progression to acute phase in chronic myelogenous leukemia Leukemia 5(11): 1012-1013Decker, R.W.; Ho, W.G.; Champlin, R.E. 1987: Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia Cancer Treatment Reports 71(9): 881-882
Vogler, W.R.; Velez-Garcia, E.; Omura, G.; Raney, M. 1989: A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia Seminars in Oncology 16(1 Suppl 2: 21-24
Zittoun, R.; Mandelli, F.; Willemze, R.; de Witte, T.; Tura, S.; Ferrini, P.R.; Stryckmans, P.; Gattringer, C.; Petti, M.C.; Solbu, G. 1992: Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase IIi trial (AML8 A). the EORTC Leukemia Cooperative Group and the GIMEMA Group Leukemia 6(Suppl 2): 114-115
Rothenberg, M.E.; Caulfield, J.P.; Austen, K.F.; Hein, A.; Edmiston, K.; Newburger, P.E.; Stevens, R.L. 1987: Biochemical and morphological characterization of basophilic leukocytes from two patients with myelogenous leukemia Journal of Immunology 138(8): 2616-2625
Alsabti, E.A.; Taleb, A.M.; Raji, H.M.; Kalil, O.Z.; Saleh, K.A. 1979: Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia Japanese Journal of Experimental Medicine 49(3): 157-168
Dhingra, K.; Talpaz, M.; Kantarjian, H.; Ku, S.; Rothberg, J.; Gutterman, J.U.; Kurzrock, R. 1991: Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression Leukemia 5(3): 191-195
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Shumak, K.H.; Baker, M.A.; Taub, R.N.; Coleman, M.S. 1980: Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 40(11): 4048-4052
Anderson, J.K.; Moore, J.O.; Metzgar, R.S. 1979: Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 39(12): 4810-4815
Koloskov, A.V.; Mamaev, N.N. 1996: Prognostic significance of the activity of nucleolar organizer regions in megakaryocytes from patients with acute lymphoblastic leukemia Gematologiia i Transfuziologiia 41(1): 23-25
Mittal, R.R.; Kullar, J.; Sethi, P.S. 2000: Skin changes in acute myelogenous leukemia Indian Journal of Dermatology Venereology and Leprology 66(5): 266-267
Ghaddar, H.; Anderlini, P.; Estey, E. 1995: Treatment of acute myelogenous leukemia New England Journal of Medicine 332(25): 1717-1718; Author Reply 1718-1719
Meisenberg, B. 1995: Treatment of acute myelogenous leukemia New England Journal of Medicine 332(25): 1718; Author Reply 1718-1719
Gale, R.P.; Butturini, A. 1991: Strategies for acute myelogenous leukemia Bone Marrow Transplantation 7(Suppl 2): 58
Lie, S.O. 1974: Acute myelogenous leukemia in children Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(32): 2232-2234
Estey, E.H. 2002: Treatment of acute myelogenous leukemia Oncology 16(3): 343-352; 355-356; Discussion 357 362 365-366
Gale, R.P.; Foon, K.A. 1987: Therapy of acute myelogenous leukemia Seminars in Hematology 24(1): 40-54
Suciu, S.; Solbu, G.; Zittoun, R.; Hayat, M.; Willemze, R.; de Witte, T.; Mandelli, F. 1991: Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA Bone Marrow Transplantation 7(Suppl 2): 34
Mohanakumar, T.; Russell, E.C.; Metzgar, R.S.; Dunn, N.; Phibbs, M.; McWilliams, N.B.; Maurer, H.M. 1979: Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens Journal of the National Cancer Institute 62(5): 1163-1167